DETAILED DESCRIPTION What is claimed: 1. [N-Ac-D-2-Nal . sup. 1,pCl-D-Phe. sup. 2,D-3-Pal. sup. 3,D-Arg. sup. 6,D-Ala. sup. 10 ]-LHRH. 2. Analogs of LHRH wherein position 1 is N-Ac-pCl-D-Phe, N-Ac-D-2-Nal, or N-Ac-3,4-diCl-D-Phe; position 2 is pCl-D-Phe; position 3 is D-2-Pal, D-3-Pal, D-4-Pal, or D-Trp; position 6 is D-2-Pal, D-3-Pal, D-4-Pal, or D-Arg, with at least one of position 3 or 6 being D-2-Pal, D-3-Pal, or D-4-Pal; and position 10 is D-Ala or the unsubstituted normally occuring Gly. 3. The LHRH analog of claim 2 which is [N-Ac-(pCl-D-Phe). sup. 1,2, D-3-Pal. sup. 3, D-Arg. sup. 6, D-Ala. sup. 10 ]-LHRH. 4. The LHRH analog of claim 2 which is [N-Ac-(pCl-D-Phe). sup. 1,2, D-2-Pal. sup. 3, D-Arg. sup. 6, D-Ala. sup. 10 ]-LHRH. 5. The LHRH analog of claim 2 which is [N-Ac-(pCl-D-Phe). sup. 1,2, D-4-Pal. sup. 3, D-Arg. sup. 6, D-Ala. sup. 10 ]-LHRH. 6. The LHRH analog of claim 2 which is [N-Ac-(pCl-D-Phe). sup. 1,2, D-Trp. sup. 3, D-3-Pal. sup. 6, D-Ala. sup. 10 ]-LHRH. 7. The LHRH analog of claim 2 which is [N-Ac-(pCl-D-Phe). sup. 1,2, D-3-Pal. sup. 3,6, D-Ala. sup. 10 ]-LHRH. 8. The LHRH analog of claim 2 which is [N-Ac-(pCl-D-Phe). sup. 1,2, D-4-Pal. sup. 3,6, D-Ala. sup. 10 ]-LHRH. 9. The LHRH analog of claim 2 which is [N-Ac-(pCl-D-Phe). sup. 1,2, D-3-Pal. sup. 3,6 ]-LHRH. 10. The LHRH analog of claim 2 which is [N-Ac-3,4-diCl-D-Phe. sup. 1, pCl-D-Phe. sup. 2, D-3-Pal. sup. 3, D-Arg. sup. 6, D-Ala. sup. 10 ]-LHRH.
Description:
BACKGROUND OF THE INVENTION During the decade, over a thousand analogs of the luteinizing hormone releasing hormone (LHRH) have been internationally synthesized, some of which were significant agonists, "super-agonists" or antagonists. The biological goal of antagonists of LHRH is effective and potent antiovulatory activity toward control of conception. Folkers, Humphries and Bowers [Z. Naturforsch. 37b, 246-249 (1982)] critiqued the evolution of design and achievement of inhibitors of LHRH as inhibitors of ovulation, based on the research of many investigators. A recent significant advance in sequence changes to increase antiovulatory potency was reported by Coy et al
|